CD47 and cancer: In this respect, the cancer cell-specific peptides CDX (FKESWREARGTRIERG) and CREKA (Cys-Arg-Glu-Lys-Ala) were introduced to the N-terminal of CD47, and parent cells were transfected with a plasmid coding for the peptide–CD47 fusion to produce modified EVs.